Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TR 987 in Chronic Venous Insufficiency Ulcers
NCT03154619Phase 2Active, not recruiting
- Sponsor
- SerenaGroup
- Start
- Nov 2016
- Primary completion
- Apr 2019
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in venous leg ulcer (VLU) comparing TR 987 with Placebo (2 arms). Primary endpoint: Time to complete wound closure at 12 weeks. Started Nov 2016; status: active, not recruiting.
02
Drugs
TR-987
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT03154619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03154619.